Original Article
Pawittra Puangsuwan, Juthathip Suphanklang, Jutikan Imsub, Sansanee Sangwanit, Chesda Udommongkol
Direct factor Xa inhibitors oral anticoagulants
(DOACs) including rivaroxaban, apixaban and
edoxaban have been shown to be equivalent or
superior to warfarin for prevention of stroke or
systemic embolism and DOACs have lower rates of
major bleeding in patients with non-valvular atrial
fibrillation (NVAF).
ตุลาคม - ธันวาคม 2565